parkinson glutathione oxidative ipsc crispr CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease Parkinson's disease: pathogenesis and therapeutic
Description
Bass et al., 2013
selenium), all three treatments lowered TPOAb and TGAb titers compared to baseline
All other data are available in the article and its Supplementary files
D.AllisC
